Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 01, 2015 6:16 AM ET

Diversified Consumer Services

Company Overview of Johns Hopkins School of Medicine

Company Overview

Johns Hopkins School of Medicine is an educational institution that offers training in medical disciplines. It offers doctorate programs for Medicinae Doctor (M.D.) and Philosophiae Doctor (Ph. D.). In addition, it offers a biomedical engineering program. The school provides education in medical disciplines such as Anesthesiology and Critical Care Medicine, Biological Chemistry, Cell Biology, Emergency Medicine, Neuroscience, Oncology, Orthopedic Surgery, Pathology, Pediatrics, Physiology, Radiology, Surgery, and Urology. Johns Hopkins School of Medicine is based in Baltimore, Maryland. The School of Medicine is a subsidiary of the Johns Hopkins University.

720 Rutland Avenue

Baltimore, MD 21205-2196

United States



Key Executives for Johns Hopkins School of Medicine

Director of Physiology
Compensation as of Fiscal Year 2014.

Johns Hopkins School of Medicine Key Developments

Compugen Ltd. Announces Initiation of Multi-Year Research Collaboration with Johns Hopkins School of Medicine

Compugen Ltd. announced the initiation of a multi-year research collaboration with Johns Hopkins University, School of Medicine, on evaluating immune checkpoint candidates. The project will be directed by Prof. Drew Pardoll and Dr. Charles Drake of John Hopkins. Prof. Pardoll and Dr. Drake, members of Compugen's Scientific Advisory Board, are pioneers in the field of immuno-oncology. The collaboration will focus on further evaluation of selected novel B7/CD28-like immune checkpoint candidates discovered by Compugen for the potential treatment of cancer. This evaluation will include the candidates' differentiation profile with respect to known checkpoints and their potential to serve either for monotherapy or in combination with other cancer treatments. This collaborative research will expand Compugen's ongoing assessment of the biology and mechanism of actions of its novel B7/CD28-like immune checkpoint proteins, and provide access to the world-class immuno-oncology research tools and expertise at Johns Hopkins University. The specific studies under the collaboration will assist Compugen in further substantiating the potential of its novel proteins as targets for cancer immunotherapy. It is anticipated that the results of this collaboration will significantly broaden the underlying scientific knowledge of Compugen's targets and will support their translation toward the clinic.

Johns Hopkins University School of Medicine Presents at Southeast BIO Investor & Partnering Forum, Nov-07-2013 08:30 AM

Johns Hopkins University School of Medicine Presents at Southeast BIO Investor & Partnering Forum, Nov-07-2013 08:30 AM. Venue: Jefferson Hotel, Richmond, Virginia, United States. Speakers: Elizabeth Good Mazhari.

Similar Private Companies By Industry

Company Name Region, Inc. United States
Kennedy Memorial Gardens, Inc. United States
Employment Services, Inc. United States
Charles S. Zeiler & Son, Inc. United States
BrightCurrent, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Johns Hopkins School of Medicine, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at